S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:PATH

UiPath Stock Forecast, Price & News

$34.73
-0.59 (-1.67%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$33.59
$35.80
50-Day Range
$34.73
$55.95
52-Week Range
$33.59
$90.00
Volume
6.02 million shs
Average Volume
4.31 million shs
Market Capitalization
$18.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive PATH News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.


UiPath logo

About UiPath

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows. The company also offers UiPath Robots, which emulates human behavior to execute the processes built in UiPath Studio; and UiPath Orchestrator that tracks and logs robot activity, along with what people do in tandem to maintain strict compliance and governance through dashboards and visualization tools. In addition, it provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.

Headlines

UiPath (NASDAQ:PATH) Sets New 1-Year Low at $34.92
January 21, 2022 |  americanbankingnews.com
UiPath Stock Rises. Fast Growth Warrants an Upgrade.
January 20, 2022 |  finance.yahoo.com
UiPath (NASDAQ:PATH) Upgraded to "Outperform" by Oppenheimer
January 20, 2022 |  americanbankingnews.com
UiPath shares lost another 6.3% last week
January 17, 2022 |  msn.com
UiPath (NASDAQ:PATH) Sets New 52-Week Low at $37.00
January 14, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:PATH
Phone
N/A
Fax
N/A
Employees
2,863
Year Founded
2005

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$18.24 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
12/08/2021
Today
1/22/2022
Fiscal Year End
1/31/2022

Social Links


MarketRank

Overall MarketRank

2.11 out of 5 stars

Business Services Sector

150th out of 455 stocks

Prepackaged Software Industry

129th out of 284 stocks

Analyst Opinion: 4.3Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












UiPath (NASDAQ:PATH) Frequently Asked Questions

Is UiPath a buy right now?

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" UiPath stock.
View analyst ratings for UiPath
or view top-rated stocks.

How has UiPath's stock price been impacted by COVID-19?

UiPath's stock was trading at $18.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PATH shares have increased by 92.9% and is now trading at $34.73.
View which stocks have been most impacted by COVID-19
.

How were UiPath's earnings last quarter?

UiPath Inc. (NASDAQ:PATH) posted its earnings results on Wednesday, December, 8th. The healthcare company reported ($0.17) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.13. The healthcare company earned $220.82 million during the quarter, compared to the consensus estimate of $209.23 million. UiPath's quarterly revenue was up 49.9% compared to the same quarter last year.
View UiPath's earnings history
.

What guidance has UiPath issued on next quarter's earnings?

UiPath issued an update on its fourth quarter 2022 earnings guidance on Wednesday, December, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $281 million-$283 million, compared to the consensus revenue estimate of $281.12 million.

What price target have analysts set for PATH?

21 brokerages have issued 12 month price targets for UiPath's stock. Their forecasts range from $40.00 to $85.00. On average, they anticipate UiPath's stock price to reach $66.71 in the next year. This suggests a possible upside of 92.1% from the stock's current price.
View analysts' price targets for UiPath
or view top-rated stocks among Wall Street analysts.

What are Wall Street analysts saying about UiPath stock?

Here are some recent quotes from research analysts about UiPath stock:
  • 1. According to Zacks Investment Research, "UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New York, United States. " (12/14/2021)
  • 2. The analyst says his price target cut reflects his updated discount cash flow model, but he also recommends that investors take advantage of the broad weakness that has impacted software as an attractive buying opportunity to buy UiPath for its long-term compounding growth story. Tillman further points to the company's record net new ARR, "constructive" Q4 outlook, and a variety of new innovations in the pipeline such as automation bots for Mac users, multi-cloud multi-platform capabilities, automation cloud traction, and task/process mining." (12/9/2021)
  • 3. The analyst notes UiPath delivered another "solid" beat across top-line metrics for Q3, including a quarterly record for net new ARR and total revenue growth of +50%. While Q3 was strong, the full-year ARR guide increased by $22M, implying a modest $2M raise post the $20M Q3 beat, Turrin adds. With Q3 results coming in clean, he expects investor conversation will focus in on what's ahead for new business activity into a seasonally strong Q4 and the potential for pent-up automation demand in a tight labor market heading into fiscal 2023. While UiPath continues to blaze a trail toward broad-based RPA adoption, current valuation levels and a rapidly evolving market backdrop leave the analyst more balanced on shares. " (12/9/2021)

Who are UiPath's key executives?

UiPath's management team includes the following people:
  • Mr. Daniel Solomon Dines, Co-Founder, CEO, & Chairman (Age 49)
  • Mr. Marius Tirca, Co-Founder & CTO
  • Mr. Ashim Gupta, Chief Financial Officer (Age 42) (LinkedIn Profile)
  • Mr. Brad C. Brubaker, Gen. Counsel, Chief Legal Officer & Sec. (Age 57) (LinkedIn Profile)
  • Mr. Robert B. Patrick, Chief Marketing Officer (Age 49)
  • Mr. Christopher Townsend, VP of Federal Sales
  • Mr. Vijay Khanna, Chief Corp. Devel. Officer
  • Ms. Bettina H. Koblick, Chief People Officer (Age 55)
  • Mr. Vargha Moayed, Chief Strategy Officer
  • Mr. Chris Klayko, Sr. VP & MD of Americas

What other stocks do shareholders of UiPath own?

When did UiPath IPO?

(PATH) raised $990 million in an initial public offering (IPO) on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities served as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the NASDAQ under the ticker symbol "PATH."

Who are UiPath's major shareholders?

UiPath's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vista Wealth Management Group LLC (0.04%), Royal London Asset Management Ltd. (0.01%), Cutler Group LP (0.00%), Parallel Advisors LLC (0.00%), Kestra Private Wealth Services LLC (0.00%) and Archford Capital Strategies LLC (0.00%). Company insiders that own UiPath stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends for UiPath
.

Which major investors are selling UiPath stock?

PATH stock was sold by a variety of institutional investors in the last quarter, including Vista Wealth Management Group LLC, and AdvisorNet Financial Inc. Company insiders that have sold UiPath company stock in the last year include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert, and Thomas Neergaard Hansen.
View insider buying and selling activity for UiPath
or view top insider-selling stocks.

Which major investors are buying UiPath stock?

PATH stock was purchased by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Cutler Group LP, Parallel Advisors LLC, Kestra Private Wealth Services LLC, Lattice Capital Management LLC, U.S. Capital Wealth Advisors LLC, New England Research & Management Inc., and IFP Advisors Inc.
View insider buying and selling activity for UiPath
or or view top insider-buying stocks.

How do I buy shares of UiPath?

Shares of PATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $34.73.

How much money does UiPath make?

UiPath has a market capitalization of $18.24 billion.

How many employees does UiPath have?

UiPath employs 2,863 workers across the globe.

Does UiPath have any subsidiaries?

The following companies are subsidiares of UiPath: Magna View BV, Process Gold International BV, ProcessGold, StepShot, UiPath AB, UiPath Australia Pty Ltd, UiPath Canada, UiPath China - Shanghai, UiPath France SAS, UiPath GMBH, UiPath Hong Kong, UiPath KK, UiPath Limited, UiPath Ltd. (India), UiPath Ltd. (SG), UiPath Ltd. (UK), UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath SRL, UiPath South Korea, and UiPath Switzerland GmbH.

When was UiPath founded?

UiPath was founded in 2005.

What is UiPath's official website?

The official website for UiPath is www.nupathe.com.

Where are UiPath's headquarters?

How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company can be reached via email at [email protected].


This page was last updated on 1/22/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.